guo rong ping - Search Results

Year	Number of Results
2002	2
2003	1
2004	3
2005	3
2006	10
2007	3
2008	3
2009	4
2010	2
2011	4
2012	8
2013	4
2014	2
2015	11
2016	7
2017	6
2018	5
2019	7
2020	8
2021	19
2022	3
2023	3
2024	0

1

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Li SH, Mei J, Cheng Y, Li Q, Wang QX, Fang CK, Lei QC, Huang HK, Cao MR, Luo R, Deng JD, Jiang YC, Zhao RC, Lu LH, Zou JW, Deng M, Lin WP, Guan RG, Wen YH, Li JB, Zheng L, Guo ZX, Ling YH, Chen HW, Zhong C, Wei W, Guo RP. Li SH, et al. Among authors: guo rp. J Clin Oncol. 2023 Apr 1;41(10):1898-1908. doi: 10.1200/JCO.22.01142. Epub 2022 Dec 16. J Clin Oncol. 2023. PMID: 36525610 Free PMC article. Clinical Trial.

2

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.

Li QJ, He MK, Chen HW, Fang WQ, Zhou YM, Xu L, Wei W, Zhang YJ, Guo Y, Guo RP, Chen MS, Shi M. Li QJ, et al. Among authors: guo rp. J Clin Oncol. 2022 Jan 10;40(2):150-160. doi: 10.1200/JCO.21.00608. Epub 2021 Oct 14. J Clin Oncol. 2022. PMID: 34648352 Clinical Trial.

3

Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.

Lin WP, Xing KL, Fu JC, Ling YH, Li SH, Yu WS, Zhang YF, Zhong C, Wang JH, Chen ZY, Lu LH, Wei W, Guo RP. Lin WP, et al. Among authors: guo rp. JAMA Netw Open. 2021 Sep 1;4(9):e2125055. doi: 10.1001/jamanetworkopen.2021.25055. JAMA Netw Open. 2021. PMID: 34515782 Free PMC article.

4

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

He M, Li Q, Zou R, Shen J, Fang W, Tan G, Zhou Y, Wu X, Xu L, Wei W, Le Y, Zhou Z, Zhao M, Guo Y, Guo R, Chen M, Shi M. He M, et al. JAMA Oncol. 2019 Jul 1;5(7):953-960. doi: 10.1001/jamaoncol.2019.0250. JAMA Oncol. 2019. PMID: 31070690 Free PMC article. Clinical Trial.

5

Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma.

Ling YH, Liu MN, Yin YX, Zhou ZG, Chen JW, Wei W, Yun JP, Xie D, Guo RP, Cai MY. Ling YH, et al. Among authors: guo rp. Signal Transduct Target Ther. 2023 Jun 23;8(1):244. doi: 10.1038/s41392-023-01446-z. Signal Transduct Target Ther. 2023. PMID: 37349321 Free PMC article. No abstract available.

6

Recent Advances in Local Thermal Ablation Therapy for Hepatocellular Carcinoma.

Deng M, Li SH, Guo RP. Deng M, et al. Among authors: guo rp. Am Surg. 2023 May;89(5):1966-1973. doi: 10.1177/00031348211054532. Epub 2021 Nov 8. Am Surg. 2023. PMID: 34743609 Review.

7

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent.

Kan A, Le Y, Zhang YF, Duan FT, Zhong XP, Lu LH, Ling YH, Guo RP. Kan A, et al. Among authors: guo rp. J Cancer. 2018 Jun 14;9(14):2415-2427. doi: 10.7150/jca.24406. eCollection 2018. J Cancer. 2018. PMID: 30026838 Free PMC article.

8

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.

Xu YJ, Lai ZC, He MK, Bu XY, Chen HW, Zhou YM, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Shi M, Li QJ. Xu YJ, et al. Among authors: guo rp. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211063848. doi: 10.1177/15330338211063848. Technol Cancer Res Treat. 2021. PMID: 34898313 Free PMC article.

9

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.

Liu J, Xu R, Mai SJ, Ma YS, Zhang MY, Cao PS, Weng NQ, Wang RQ, Cao D, Wei W, Guo RP, Zhang YJ, Xu L, Chen MS, Zhang HZ, Huang L, Fu D, Wang HY. Liu J, et al. Among authors: guo rp. Theranostics. 2020 Jun 12;10(17):7527-7544. doi: 10.7150/thno.45989. eCollection 2020. Theranostics. 2020. PMID: 32685003 Free PMC article.

10

Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.

Deng M, Fang L, Li SH, Zhao RC, Mei J, Zou JW, Wei W, Guo RP. Deng M, et al. Among authors: guo rp. Mutagenesis. 2021 Oct 6;36(5):369-379. doi: 10.1093/mutage/geab032. Mutagenesis. 2021. PMID: 34467992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year